SIM
SRRA

Spark Investment Management’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History

Spark Investment Management’s Portfolio SRRA Stock Details SRRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-1,311
Closed -$17K – 568
2019
Q4 		$17K Sell
1,311
-302
-19% -$3.94K ﹤0.01% 538
2019
Q3 		$25K Sell
1,613
-5,185
-76% -$99.2K ﹤0.01% 383
2019
Q2 		$152K Sell
6,798
-3,122
-31% -$151K 0.01% 483
2019
Q1 		$678K Sell
9,920
-445
-4% -$28.6K 0.03% 382
2018
Q4 		$547K Buy
10,365
+632
+6% +$40.4K 0.04% 383
2018
Q3 		$661K Buy
9,733
+1,460
+18% +$132K 0.04% 442
2018
Q2 		$979K Buy
8,273
+2,178
+36% +$219K 0.06% 372
2018
Q1 		$504K Buy
+6,095
New +$691K 0.03% 400
2017
Q4 		– Sell
-4,718
Closed -$292K – 847
2017
Q3 		$292K Buy
+4,718
New +$277K 0.02% 558

Other funds holding SRRA

VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
MP
Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Spark Investment Management's SRRA Position: Q1 2020 in Review

Spark Investment Management sold out of Sierra Oncology, Inc. Common Stock (SRRA) in Q1 2020, closing a stake of 1,311 shares — an estimated $17K sold.

Spark Investment Management first reported a position in SRRA in Q3 2017 and held it in 9 quarters. The position peaked at $979K in Q2 2018. 22 funds tracked by Wall St. Rank hold SRRA as of Q1 2020.

  • Spark Investment Management reported no remaining Sierra Oncology, Inc. Common Stock position as of Q1 2020 after selling out during the quarter.
  • Spark Investment Management sold 1,311 Sierra Oncology, Inc. Common Stock shares in Q1 2020, an estimated $17K.
  • Spark Investment Management first reported a position in Sierra Oncology, Inc. Common Stock in Q3 2017 and held it in 9 quarters.
  • Spark Investment Management's Sierra Oncology, Inc. Common Stock position peaked at $979K in Q2 2018.
  • 22 funds tracked by Wall St. Rank held Sierra Oncology, Inc. Common Stock as of Q1 2020.

Based on Spark Investment Management's 13F filing for Q1 2020, filed 12 May 2020.